Back
Agios Pharmaceuticals, Inc. Stock Predictions
Most Pre-IPO Big Tech Shifts Look Like This at the Start
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
21
AGIO
Agios Pharmaceuticals, Inc.
Last Price:
$26.52
Seasonality Move:
3.3%
7 Day Trial
ALL ACCESS PASS
$
7
This Company Solves Remote Work with Virtual HQs
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.comAgios Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Agios Pharmaceuticals, Inc. has on average historically risen by 22.4% based on the past 12 years of stock performance.
-
Agios Pharmaceuticals, Inc. has risen higher in 6 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Agios Pharmaceuticals, Inc. Stock Undervalued?The current Agios Pharmaceuticals, Inc. [AGIO] share price is $26.53. The Score for AGIO is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
AGIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Agios Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Agios Pharmaceuticals, Inc. has on average historically risen by 22.4% based on the past 12 years of stock performance.
Agios Pharmaceuticals, Inc. Stock Rating
Sell
21
Agios Pharmaceuticals, Inc. (AGIO)
is a Sell
Is Agios Pharmaceuticals, Inc. overpriced?
-
Agios Pharmaceuticals, Inc. has risen higher in 6 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Agios Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
agios.com
52-Week Data
52-Week High:
46.00
52-Week Low:
22.24
Prediction Charts
Market Cap:
1.5B
Price in USD:
26.53
Volume:
1.2M
Beta:
1.35
Technical Analysis
SMA50:
27.46
SMA100:
33.80
SMA200:
34.14
52-Wk Change:
-22.92%
Stock Predictions
-
Is Agios Pharmaceuticals, Inc. stock public?Yes, Agios Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Agios Pharmaceuticals, Inc. stock quote today?The Agios Pharmaceuticals, Inc. stock price is 26.53 USD today.
-
How to buy Agios Pharmaceuticals, Inc. stock online?You can buy Agios Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 26.50 | 26.68 | 27.08 | 26.25 |
| Jan-21 | 26.73 | 27.17 | 27.32 | 26.42 |
| Jan-22 | 27.25 | 28.66 | 28.75 | 27.13 |
| Jan-23 | 28.57 | 28.54 | 29.10 | 27.82 |
| Jan-26 | 28.50 | 28.83 | 29.17 | 28.03 |
| Jan-27 | 28.80 | 28.67 | 29.93 | 28.42 |
| Jan-28 | 28.79 | 28.31 | 29.04 | 28.22 |
| Jan-29 | 28.30 | 27.61 | 28.57 | 27.41 |
| Jan-30 | 27.46 | 27.44 | 27.92 | 26.95 |
| Feb-2 | 27.18 | 28.16 | 28.71 | 26.53 |
| Feb-3 | 28.11 | 27.93 | 28.71 | 27.60 |
| Feb-4 | 28.19 | 27.70 | 28.19 | 27.55 |
| Feb-5 | 27.48 | 26.57 | 28.07 | 26.45 |
| Feb-6 | 27.03 | 26.53 | 27.43 | 26.50 |
Agios Pharmaceuticals, Inc. Earnings
Agios Pharmaceuticals, Inc. Earnings Report: Per Share Agios Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Agios Pharmaceuticals, Inc. Forecast Revenue Growth
Agios Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Agios Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.44 per share, and an increase next year of $1.09 per share.
* Agios Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.